Lucca, F.; Bezzerri, V.; Danese, E.; Olioso, D.; Peserico, D.; Boni, C.; Cucchetto, G.; Montagnana, M.; Tridello, G.; Meneghelli, I.;
et al. Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation. Int. J. Mol. Sci. 2023, 24, 908.
https://doi.org/10.3390/ijms24020908
AMA Style
Lucca F, Bezzerri V, Danese E, Olioso D, Peserico D, Boni C, Cucchetto G, Montagnana M, Tridello G, Meneghelli I,
et al. Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation. International Journal of Molecular Sciences. 2023; 24(2):908.
https://doi.org/10.3390/ijms24020908
Chicago/Turabian Style
Lucca, Francesca, Valentino Bezzerri, Elisa Danese, Debora Olioso, Denise Peserico, Christian Boni, Giulia Cucchetto, Martina Montagnana, Gloria Tridello, Ilaria Meneghelli,
and et al. 2023. "Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation" International Journal of Molecular Sciences 24, no. 2: 908.
https://doi.org/10.3390/ijms24020908
APA Style
Lucca, F., Bezzerri, V., Danese, E., Olioso, D., Peserico, D., Boni, C., Cucchetto, G., Montagnana, M., Tridello, G., Meneghelli, I., Ros, M., Lippi, G., & Cipolli, M.
(2023). Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation. International Journal of Molecular Sciences, 24(2), 908.
https://doi.org/10.3390/ijms24020908
